Targeted Therapy for BRAF(V600E) Malignant Astrocytoma

PURPOSE: Malignant astrocytomas (MAs) are aggressive central nervous system tumors with poor prognosis. Activating mutation of BRAF (BRAF(V600E)) has been reported in a subset of these tumors, especially in children. We have investigated the incidence of BRAF(V600E) in additional pediatric patient c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Nicolaides, Theodore P., Li, Huifang, Solomon, David A., Hariono, Sujatmi, Hashizume, Rintaro, Barkovich, Krister, Baker, Suzanne J., Paugh, Barbara S., Jones, Chris, Forshew, Tim, Hindley, Guy F., Hodgson, J. Graeme, Kim, Jung-Sik, Rowitch, David H., Weiss, William A., Waldman, Todd A., James, C. David
Format: Artigo
Idioma:Inglês
Publicat: 2011
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3638050/
https://ncbi.nlm.nih.gov/pubmed/22038996
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-1456
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars